The Fourth Round Table for the Triple I for Global Health

The 4th Round Table meeting among the Partners of "Impact Investment Initiative for Global Health (Triple I for GH)" took place on 13th December 2024. 

Ambassador Suzuki Hideo provided an update on Triple I for GH's progress, including major outreach events conducted this year such as the side event during the United Nations General Assembly in September 2024. Ambassador Suzuki then outlined Triple I's future work plan according to the three pillars of activities - (1) expand awareness of impact investing, (2) support development of models for impact investing, and (3) policy & enabling environments; advance incentives for impact investment - which includes publication of a practitioner guide and recommendations related to impact measurement and management (IMM), as well as publication of recommendations on policies and enabling environments.

Dr. Julian Peat from Global Health Investment Corporation, an Advisory & Advocacy Partner of Triple I for GH, introduced their Catalytic Health Investment Platform (CHIP), which was launched this year in collaboration with the Government of Germany (KfW-BMZ). Dr. Peat highlighted how the innovative platform aims to catalyze a vibrant and sustainable ecosystem for health innovations in LMICs by providing patient impact capital through fund investments, direct investments, and grants. CHIP supports health innovation across the entire healthcare value chain, from R&D ecosystem, biotech and medtech to health systems, access and delivery. It funds traditional areas like infectious diseases and sexual, maternal and child health, while also addressing non-communicable diseases and health issues related to climate and the environment.

Co-Chair Mr. Steve Davis introduced the work of the Working Group established under the third Pillar to examine and consider the role of governments, development finance institutions (DFIs), multilateral development banks (MDBs) and international organizations, and how these important actors can stimulate impact investing into global health. The Secretariat introduced key aspects of draft policy recommendations that are being developed through Working Group discussions as well as interviews and surveys. 

Breakout discussions identified key elements in developing the policy recommendations, including shaping an enabling regulatory environment and having a strong alignment between public and private sectors. Participants also discussed where the gaps may be in existing IMM frameworks and the need to consider the innovation in the earlier stages of the healthcare value chain.

Overall, the roundtable meeting saw valuable exchange of experiences and views to expand impact investment in global health sector.